ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SILO vs ELAB // DIVIDEND YIELD & FCF PAYOUT SAFETY

Silo Pharma Inc. (NASDAQ) VS. PMGC Holdings Inc. (NASDAQ) • 15-METRIC TALLY: SILO 3 — ELAB 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SILO VS. ELAB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SILO ELAB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 38.60% 31.40% +7.20 SILO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 0.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.1 25.9 +8.22 SILO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.4M $2.1M $241.8K SILO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SILO REV ELAB REV SILO GROSS % ELAB GROSS % SILO FCF ELAB FCF
FY 2025 $72.1K $590.1K 38.6% 31.4% -$4.7M -$6.4M
FY 2024 $72.1K $0 91.9% — -$3.8M -$5.5M
FY 2023 $72.1K $1.7M — — -$3.2M -$4.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SILO // BETA —
ELAB // BETA —